Identification of a Candidate Proteomic Signature to Discriminate Multipotent and Non-Multipotent Stromal Cells

• Michael Rosu-Myles ,

  * E-mail: michael.rosu-myles@hc-sc.gc.ca

  Affiliation Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, Canada

  ⨯
• Yi-Min She,

  Affiliation Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, Canada

  ⨯
• Joel Fair,

  Affiliation Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada

  ⨯
• Gauri Muradia,

  Affiliation Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, Canada

  ⨯
• Jelica Mehic,

  Affiliation Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, Canada

  ⨯
• Pablo Menendez,

  Affiliation Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research, Granada, Spain

  ⨯
• Shiv S. Prasad,

  Affiliation Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, Canada

  ⨯
• Terry D. Cyr

  Affiliation Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada, Ottawa, Canada

  ⨯